Detalles de la búsqueda
1.
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.
N Engl J Med
; 389(21): 1935-1948, 2023 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37937763
2.
Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer.
Oncology
; 102(3): 271-282, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725914
3.
D-dimer cut-off value for predicting venous thromboembolism at the initial diagnosis in Japanese patients with advanced lung cancer.
Jpn J Clin Oncol
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38769814
4.
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.
Int J Clin Oncol
; 29(2): 124-133, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160406
5.
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial.
Cancer Sci
; 114(8): 3342-3351, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37139543
6.
Clinical Outcomes after One-day or Two-day Intervals in Conditioning Regimens for allo-HCT.
J Pediatr Hematol Oncol
; 45(3): e378-e383, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161998
7.
Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.
Int J Clin Oncol
; 28(1): 69-78, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357710
8.
Osimertinib with Chemotherapy in EGFR-Mutated NSCLC. Reply.
N Engl J Med
; 390(5): 478-479, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294984
9.
A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol.
BMC Cancer
; 22(1): 1135, 2022 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36333680
10.
Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1.
BMC Cancer
; 22(1): 1325, 2022 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36528575
11.
Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302.
Int J Clin Oncol
; 27(12): 1841-1848, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36241930
12.
Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024.
Int J Clin Oncol
; 27(4): 676-683, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092535
13.
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B).
Int J Clin Oncol
; 27(1): 112-120, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34643820
14.
Early reconstitution of lymphocytes after allogenic hematopoietic stem cell transplantation affects chronic graft-versus-host disease.
Pediatr Int
; 64(1): e15222, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790056
15.
Analysis of long-term renal function in patients with malignant solid tumors: Retrospective analysis using the estimated glomerular filtration rate.
Pediatr Int
; 64(1): e15373, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36176204
16.
Perceptions of Japanese and Dutch women with early breast cancer about monitoring their quality of life.
J Psychosoc Oncol
; 40(4): 527-540, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34266363
17.
Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.
Oncology
; 99(9): 562-570, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237736
18.
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027.
BMC Cancer
; 21(1): 208, 2021 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33648453
19.
Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
Pediatr Blood Cancer
; 68(2): e28763, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33047887
20.
Paranasal sinusitis at the initiation of chemotherapy is a risk factor for invasive fungal disease in children and adolescents with cancer.
Support Care Cancer
; 29(10): 5847-5852, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33754198